179 related articles for article (PubMed ID: 25863565)
1. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
2. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
4. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
5. Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast.
Lamblin G; Oteifa M; Zinzindohoue C; Isaac S; Termine L; Bobin JY
Eur J Surg Oncol; 2001 Mar; 27(2):146-51. PubMed ID: 11289749
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
Tajima S; Mochizuki R; Sugimura H; Hoshi S
Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
[No Abstract] [Full Text] [Related]
7. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
8. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
[TBL] [Abstract][Full Text] [Related]
9. [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
Nestle-Krämling C; Bölke E; Budach W; Peiper M; Niederacher D; Janni W; Eisenberger CF; Knoefel WT; Scherer A; Baldus SE; Lammering G; Gerber PA; Matuschek C
Strahlenther Onkol; 2011 Oct; 187(10):656-64. PubMed ID: 21858416
[TBL] [Abstract][Full Text] [Related]
10. [Angiosarcoma of the skin after breast cancer radiotherapy].
Armengot-Carbó M; Roca-Estellés MJ; Quecedo-Estébanez E; Gimeno-Carpio E
Actas Dermosifiliogr; 2012; 103(6):557-9. PubMed ID: 22465258
[No Abstract] [Full Text] [Related]
11. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
Styring E; Seinen J; Dominguez-Valentin M; Domanski HA; Jönsson M; von Steyern FV; Hoekstra HJ; Suurmeijer AJ; Nilbert M
Br J Cancer; 2014 Jul; 111(2):407-12. PubMed ID: 24983371
[TBL] [Abstract][Full Text] [Related]
12. Double-edged sword of radiotherapy: a cause of secondary angiosarcoma after breast conservation therapy.
Iqbal FM; Ahmed B; Vidya R
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113794
[TBL] [Abstract][Full Text] [Related]
13. Secondary cancers after radiotherapy may appear early and atypical.
Baack T; Wenz F
Strahlenther Onkol; 2012 Jan; 188(1):91-2; author reply 92-3. PubMed ID: 22194026
[No Abstract] [Full Text] [Related]
14. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
15. Analysis of radiation-induced angiosarcoma of the breast.
Zemanova M; Rauova K; Boljesikova E; Machalekova K; Krajcovicova I; Lehotska V; Mikulova M; Svec J
Bratisl Lek Listy; 2014; 115(5):307-10. PubMed ID: 25174061
[TBL] [Abstract][Full Text] [Related]
16. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic study of angiosarcoma of the breast.
Gil-Benso R; López-Ginés C; Soriano P; Almenar S; Vazquez C; Llombart-Bosch A
Genes Chromosomes Cancer; 1994 Jul; 10(3):210-2. PubMed ID: 7522046
[TBL] [Abstract][Full Text] [Related]
19. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
Manner J; Radlwimmer B; Hohenberger P; Mössinger K; Küffer S; Sauer C; Belharazem D; Zettl A; Coindre JM; Hallermann C; Hartmann JT; Katenkamp D; Katenkamp K; Schöffski P; Sciot R; Wozniak A; Lichter P; Marx A; Ströbel P
Am J Pathol; 2010 Jan; 176(1):34-9. PubMed ID: 20008140
[TBL] [Abstract][Full Text] [Related]
20. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
